Developer docs
API playgroundTry for free, no card

Search company profiles

RxERP

Full company profile

uuid0002cmj

Namestring
RxERP
Legal namestring
RxERP Inc.
Websiteurl
rxerp.com
Company typeenum
Private
Founded yearint
2020
Descriptiontext

RxERP (RxERP Inc., Delaware C-corp) is a venture-backed SaaS company building a serialized ERP platform specifically designed for the pharmaceutical supply chain. The company serves manufacturers, wholesale distributors, 3PL providers, micro-distributors, and government pharmaceutical programs, with the core differentiator being that DSCSA serialization is embedded directly into the ERP architecture rather than layered on as a separate add-on. The platform unifies ERP, serialization, compliance, inventory, financial automation, CRM, eCommerce, and analytics modules in a single system, replacing what the company estimates is typically 4-6 disconnected tools. The company's flagship product, 'The Hub' (launched April 2026), introduces AI-native infrastructure including unit-level audit logging, automated transaction guardrails, and verified transaction rails intended to function as a system of truth across pharma trading partners. RxERP has additionally secured a licensing agreement with p-Chip Corporation to embed light-activated microtransponder identity technology and is co-sponsoring a multi-year digital traceability trial with Choice One Rx and Avantor covering over 1,000 patients through 2028.

The company monetizes through enterprise SaaS subscriptions (quote-based, annual billing with multi-year options and early termination fees), professional services for onboarding and training (up to 16 hours included), and a financing program branded as RxERP Financial in partnership with Wellgistics Health, which extends working capital of up to $350,000 per independent pharmacy and up to $1 million per wholesaler or manufacturer. Distribution combines direct enterprise field sales, a channel partnership with Wellgistics Health (network of 6,500+ pharmacies and 200+ U.S. manufacturers), and self-serve SaaS access. Headquartered in St. George, Utah, with a remote-first team across Utah, Florida, and Texas, RxERP is a subsidiary of MENDRx (branded as 'A MENDRx Company') and holds GS1 US Premier Solution Partner status, AICPA SOC 2 Type 2 attestation, and memberships in HDA and NCPA. Leadership includes founder and CEO Steve Madsen (pharma supply chain operator background), COO Tony Madsen, CRO Steve Garcia (ex-Podium, ex-DigitalOcean), and CTO Cyrus Dean.

Short descriptiontext

RxERP provides a serialized ERP platform purpose-built for the pharmaceutical supply chain, serving manufacturers, wholesalers, distributors, 3PLs, micro-distributors, and government programs with DSCSA-compliant ERP, compliance, inventory, and AI-powered analytics.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
11–50
akta.pro rankint
HeadquartersSaint George, United States
HQ citystring
Saint George
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Offices1 record

Each record includes

City, Country, Type, Description, Source

Keyword5 values
pharmaceutical ERP software, DSCSA compliance, drug serialization platform, pharma supply chain, serialized ERP
Industry1 code
PRIMARYHDAEAEAH
Healthcare Provider ERP (Hospital Operations, Supply Chain, Finance)
Hardware, Technology & Telecom/Enterprise Platforms & Databases/Enterprise Resource Planning (ERP) Platforms
NAICS code1 code
  • Software Publishers5132
SIC code1 code
  • Services-Computer Integrated Systems Design7373
Product category
Pharmaceutical Serialized ERP Software
Social media profiles4 records
GTM motion2 records

Each record includes

Type, Description, Source

Revenue model3 records
1SaaS Subscription
TypeSubscription Recurring
Description

RxERP operates as a SaaS company providing access to its serialized ERP platform. Services are delivered through web applications (Admin App, Mobile App, eCommerce Store). Billing is monthly or annual based on subscription tiers, with fees detailed per invoice. The company is described as revenue-generating and venture-backed.

rxerp.com
2Financing Program Revenue
TypeTransaction Fee
Description

RxERP Financial partnership with Wellgistics Health enables financing offerings to pharmacies and supply chain partners (up to $350,000 per independent pharmacy, up to $1 million per wholesaler/manufacturer), likely generating transaction or referral fees.

citizen-times.com
3Professional Services
TypeProfessional Services
Description

Implementation, training, and professional services provided during onboarding. Initial onboarding and training included (up to 16 hours) at no extra cost. Additional training and on-site services available at agreed rates.

rxerp.com
Marketing channels8 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels3 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Personnel, Technology or R&D, Marketing or Sales, Operations, Infrastructure
Pricing details1 tier
1Enterprise SaaS subscription for pharmaceutical supply chain operators
ModelSubscriptionBilling cadenceAnnual
Notes

Quote-based / Not publicly disclosed. Enterprise pricing varies by company size, modules selected, and transaction volume. Annual and multi-year billing options available.

rxerp.com
GTM typeB2B
B2B
Offering typeSoftware
Software
Brand1 of 2 records shown
1The Hub
Description

AI-native serialized ERP platform upgrade featuring unit-level audit logging, infrastructure-grade capabilities, and automated transaction guardrails for pharmaceutical supply chain.

businesswire.com
+1 more record
Core offering1 text field

RxERP provides a fully serialized, AI-native ERP platform built specifically for the pharmaceutical supply chain, unifying DSCSA serialization, compliance, inventory, financial automation, CRM, eCommerce, and analytics in a single system. The platform replaces 4-6 disconnected tools with one system of record serving manufacturers, wholesale distributors, 3PL providers, micro-distributors, and government programs. The 2026 Hub upgrade added unit-level audit logging, automated transaction guardrails, and p-Chip microtransponder integration.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 5 values shown
  • Replaces 4-6 disconnected tools with one system of record
+4 more records
Product overview1 text field

RxERP offers a unified, fully serialized ERP platform built specifically for the pharmaceutical supply chain. The core RxERP Platform integrates ERP, DSCSA serialization, and operational workflows into one system, with the major AI-native upgrade called 'The Hub' providing unit-level audit logging and automated transaction guardrails. The platform includes built-in modules for Compliance Management, Business Intelligence Analytics, Financial Automation, Inventory Optimization, CRM, eCommerce, and AI Integration. Specialized solutions serve distinct segments: Wholesaler/Distributor ERP, Micro-Distributor ERP, 3PL Provider ERP, Manufacturer ERP, and Government ERP. Additional offerings include Data Validation Rules as a feature module and Validation Plan Services. The platform is designed to eliminate disconnected tools by keeping serialization inside the ERP, ensuring traceability, inventory, pricing, and compliance stay aligned across the supply chain.

Product and service1 record
1RxERP Platform
Scale indicator5 records

Each record includes

Type, Value, Description, Source

Partnership6 partners
Strategic tierFlagshipTypeStrategic or Co-development PartnerAnnounced on2026-05-26
Description

Multimillion-dollar partnership to transition Independent Pharmaceutical's entire ERP operations to RxERP's Hub platform. The collaboration strengthens compliance infrastructure as the company expands in prescription and OTC distribution, with the platform purpose-built for pharmaceutical distribution, inventory management, serialization, DSCSA compliance, and regulatory reporting.

Strategic tierCoreTypeTechnology or IntegrationAnnounced on2026-02-12
Description

Licensing agreement to integrate p-Chip's light-activated microtransponder identity technology into RxERP's pharmaceutical-focused ERP platform for DSCSA compliance. The integration embeds unit-level digital identity into prescription drug containers, enabling supply chain partners to achieve audit-ready traceability. Builds on a previous pilot program demonstrating interoperability between pharmacy operations and ERP systems.

3Choice One Rx
Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2026-01-13
Description

Partnership to conduct a trial demonstrating end-to-end digital traceability of drugs across pharmaceutical supply chains for over 1,000 patients through 2028. Trial validates compliance with DSCSA through permanently embedded microtransponder technology (p-Chip). Establishes verifiable Chain-of-Identity and Chain-of-Custody.

pharmiweb.com
Strategic tierMinorTypeStrategic or Co-development PartnerAnnounced on2026-01-13
Description

Co-sponsor of the p-Chip/Choice One Rx/RxERP digital traceability trial. Provides support for the initiative focused on establishing interoperable traceability technologies for the pharmaceutical supply chain.

Strategic tierCoreTypeGTM or Marketing PartnerAnnounced on2025-10-09
Description

Capital access program partnership offering financing of up to $350,000 per independent pharmacy and up to $1 million per wholesaler or manufacturer to Wellgistics' network of 6,500+ pharmacies and 200+ U.S. manufacturers. Integrates financing options directly into the Wellgistics/RxERP store platform with transparent terms and soft credit inquiries.

6RxERP Financial
Strategic tierCoreTypeGTM or Marketing PartnerAnnounced on2025-10-09
Description

Joint financing initiative with Wellgistics Health enabling working capital access for pharmacies and supply chain partners. RxERP Financial brand powers the capital access program integrated into the platform.

citizen-times.com
Recent move6 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight6 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

TraceLink is a leading pharmaceutical serialization and supply chain traceability network, directly comparable to RxERP's DSCSA-focused serialization capabilities, but with a broader network-orchestration focus rather than a unified ERP core.

TypeDirect peer
Description

Systech offers unit-level serialization, traceability, and authentication solutions for pharmaceutical supply chains, overlapping with RxERP's serialization-native ERP positioning for manufacturers and packagers.

TypeDirect peer
Description

rfXcel provides pharmaceutical serialization, traceability, and compliance software serving manufacturers, wholesalers, and 3PLs. It is the closest direct competitor to RxERP's DSCSA-compliance value proposition.

TypeBroad incumbent
Description

SAP is the dominant broad-incumbent ERP for large pharmaceutical manufacturers and distributors, with serialization and compliance modules that compete with RxERP's vertically-specialized pharma offering.

TypeBroad incumbent
Description

Blue Yonder provides supply chain planning and execution software used by pharmaceutical distributors and 3PLs, overlapping with RxERP's inventory, ordering, and 3PL solutions.

TypeBroad incumbent
Description

Körber offers a portfolio of pharma manufacturing, serialization, and supply chain software solutions, making it a broad incumbent peer with overlapping DSCSA and warehouse execution capabilities.

TypeDirect peer
Description

Antares Vision provides serialization, track-and-trace, and quality control solutions for the pharmaceutical industry, competing in the same DSCSA compliance and unit-level traceability space as RxERP.

TypeBroad incumbent
Description

Oracle offers broad enterprise ERP platforms used by pharma manufacturers and distributors, including serialization extensions. As a broad incumbent, it competes against RxERP for enterprise pharma wallet share.

TypeBroad incumbent
Description

Microsoft Dynamics 365 is a broad ERP/CRM platform with growing traction in regulated industries including pharma distribution, positioning it as a broad incumbent alternative to RxERP's serialized ERP.

TypeEmerging player
Description

LSPediA, now part of Veeva, provides DSCSA compliance and serialization software for the pharmaceutical supply chain, positioning it as a closely adjacent emerging player to RxERP's serialization focus.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat5 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights6 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers9 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment5 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile5 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

AI capability5 records

Each record includes

Type, Description, Source

AI maturity
App detail

Has app

Feature6 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles4 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
Compliance1 record

Each record includes

Name, Class, Description

Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds1 record

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

RxERP

Pharmaceutical Serialized ERP Softwarerxerp.com

RxERP provides a serialized ERP platform purpose-built for the pharmaceutical supply chain, serving manufacturers, wholesalers, distributors, 3PLs, micro-distributors, and government programs with DSCSA-compliant ERP, compliance, inventory, and AI-powered analytics.

What RxERP does

RxERP (RxERP Inc., Delaware C-corp) is a venture-backed SaaS company building a serialized ERP platform specifically designed for the pharmaceutical supply chain. The company serves manufacturers, wholesale distributors, 3PL providers, micro-distributors, and government pharmaceutical programs, with the core differentiator being that DSCSA serialization is embedded directly into the ERP architecture rather than layered on as a separate add-on. The platform unifies ERP, serialization, compliance, inventory, financial automation, CRM, eCommerce, and analytics modules in a single system, replacing what the company estimates is typically 4-6 disconnected tools. The company's flagship product, 'The Hub' (launched April 2026), introduces AI-native infrastructure including unit-level audit logging, automated transaction guardrails, and verified transaction rails intended to function as a system of truth across pharma trading partners. RxERP has additionally secured a licensing agreement with p-Chip Corporation to embed light-activated microtransponder identity technology and is co-sponsoring a multi-year digital traceability trial with Choice One Rx and Avantor covering over 1,000 patients through 2028.

The company monetizes through enterprise SaaS subscriptions (quote-based, annual billing with multi-year options and early termination fees), professional services for onboarding and training (up to 16 hours included), and a financing program branded as RxERP Financial in partnership with Wellgistics Health, which extends working capital of up to $350,000 per independent pharmacy and up to $1 million per wholesaler or manufacturer. Distribution combines direct enterprise field sales, a channel partnership with Wellgistics Health (network of 6,500+ pharmacies and 200+ U.S. manufacturers), and self-serve SaaS access. Headquartered in St. George, Utah, with a remote-first team across Utah, Florida, and Texas, RxERP is a subsidiary of MENDRx (branded as 'A MENDRx Company') and holds GS1 US Premier Solution Partner status, AICPA SOC 2 Type 2 attestation, and memberships in HDA and NCPA. Leadership includes founder and CEO Steve Madsen (pharma supply chain operator background), COO Tony Madsen, CRO Steve Garcia (ex-Podium, ex-DigitalOcean), and CTO Cyrus Dean.

RxERP firmographics

Firmographics
Name
RxERP
Legal name
RxERP Inc.
Website
https://rxerp.com
Company type
Private
Founded year
2020
Operating status
Operating
Headcount range
11–50 employees
Short description
RxERP provides a serialized ERP platform purpose-built for the pharmaceutical supply chain, serving manufacturers, wholesalers, distributors, 3PLs, micro-distributors, and government programs with DSCSA-compliant ERP, compliance, inventory, and AI-powered analytics.
Ownership category
akta.pro rank

RxERP industry classification

Industry
Product category
Pharmaceutical Serialized ERP Software
NAICS
Software Publishers (5132)
SIC
Services-Computer Integrated Systems Design (7373)
akta.pro industry
PRIMARYHDAEAEAH
Healthcare Provider ERP (Hospital Operations, Supply Chain, Finance)
Hardware, Technology & Telecom/Enterprise Platforms & Databases/Enterprise Resource Planning (ERP) Platforms

Keywords

  • Pharmaceutical ERP software
  • DSCSA compliance
  • Drug serialization platform
  • Pharma supply chain
  • Serialized ERP

Where RxERP is headquartered

Location

Headquarters

HQ city
Saint George
HQ country
United States
HQ region
North America

Offices1 record

Markets served

RxERP business model

Business model
GTM type
B2B
Offering type
Software
Cost components
Personnel, Technology or R&D, Marketing or Sales, Operations, Infrastructure

Revenue model

  1. SaaS Subscription: RxERP operates as a SaaS company providing access to its serialized ERP platform. Services are delivered through web applications (Admin App, Mobile App, eCommerce Store). Billing is monthly or annual based on subscription tiers, with fees detailed per invoice. The company is described as revenue-generating and venture-backed.
  2. Financing Program Revenue: RxERP Financial partnership with Wellgistics Health enables financing offerings to pharmacies and supply chain partners (up to $350,000 per independent pharmacy, up to $1 million per wholesaler/manufacturer), likely generating transaction or referral fees.
  3. Professional Services: Implementation, training, and professional services provided during onboarding. Initial onboarding and training included (up to 16 hours) at no extra cost. Additional training and on-site services available at agreed rates.

Pricing tiers

ModelBillingPrice
SubscriptionAnnualEnterprise SaaS subscription for pharmaceutical supply chain operators

Go-to-market motion2 records

Distribution channels3 records

Marketing channels8 records

RxERP product offering

Product offering

Core offering

RxERP provides a fully serialized, AI-native ERP platform built specifically for the pharmaceutical supply chain, unifying DSCSA serialization, compliance, inventory, financial automation, CRM, eCommerce, and analytics in a single system. The platform replaces 4-6 disconnected tools with one system of record serving manufacturers, wholesale distributors, 3PL providers, micro-distributors, and government programs. The 2026 Hub upgrade added unit-level audit logging, automated transaction guardrails, and p-Chip microtransponder integration.

Product overview

RxERP offers a unified, fully serialized ERP platform built specifically for the pharmaceutical supply chain. The core RxERP Platform integrates ERP, DSCSA serialization, and operational workflows into one system, with the major AI-native upgrade called 'The Hub' providing unit-level audit logging and automated transaction guardrails. The platform includes built-in modules for Compliance Management, Business Intelligence Analytics, Financial Automation, Inventory Optimization, CRM, eCommerce, and AI Integration. Specialized solutions serve distinct segments: Wholesaler/Distributor ERP, Micro-Distributor ERP, 3PL Provider ERP, Manufacturer ERP, and Government ERP. Additional offerings include Data Validation Rules as a feature module and Validation Plan Services. The platform is designed to eliminate disconnected tools by keeping serialization inside the ERP, ensuring traceability, inventory, pricing, and compliance stay aligned across the supply chain.

Differentiator

Problem solved

Functional benefit

Brands

  • The Hub: AI-native serialized ERP platform upgrade featuring unit-level audit logging, infrastructure-grade capabilities, and automated transaction guardrails for pharmaceutical supply chain.
  • RxERP Financial

Products and services

  • RxERP Platform

Quantifiable outcome

  • Replaces 4-6 disconnected tools with one system of record
  • +4 more outcomes

Companies that use RxERP

Customer profile

Named customers9 records

Segments5 records

Ideal customer profiles5 records

RxERP technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

AI capability5 records

Feature6 records

RxERP partnerships and signals

Strategic signal

Partnerships

Six partnerships are on record, tiered flagship, core and minor.

  • Independent Pharmaceutical LLCflagshipStrategic or Co-development Partner · 26 May 2026Multimillion-dollar partnership to transition Independent Pharmaceutical's entire ERP operations to RxERP's Hub platform. The collaboration strengthens compliance infrastructure as the company expands in prescription and OTC distribution, with the platform purpose-built for pharmaceutical distribution, inventory management, serialization, DSCSA compliance, and regulatory reporting.
  • p-Chip CorporationcoreTechnology or Integration · 12 February 2026Licensing agreement to integrate p-Chip's light-activated microtransponder identity technology into RxERP's pharmaceutical-focused ERP platform for DSCSA compliance. The integration embeds unit-level digital identity into prescription drug containers, enabling supply chain partners to achieve audit-ready traceability. Builds on a previous pilot program demonstrating interoperability between pharmacy operations and ERP systems.
  • Choice One RxcoreStrategic or Co-development Partner · 13 January 2026Partnership to conduct a trial demonstrating end-to-end digital traceability of drugs across pharmaceutical supply chains for over 1,000 patients through 2028. Trial validates compliance with DSCSA through permanently embedded microtransponder technology (p-Chip). Establishes verifiable Chain-of-Identity and Chain-of-Custody.
  • AvantorminorStrategic or Co-development Partner · 13 January 2026Co-sponsor of the p-Chip/Choice One Rx/RxERP digital traceability trial. Provides support for the initiative focused on establishing interoperable traceability technologies for the pharmaceutical supply chain.
  • Wellgistics HealthcoreGTM or Marketing Partner · 9 October 2025Capital access program partnership offering financing of up to $350,000 per independent pharmacy and up to $1 million per wholesaler or manufacturer to Wellgistics' network of 6,500+ pharmacies and 200+ U.S. manufacturers. Integrates financing options directly into the Wellgistics/RxERP store platform with transparent terms and soft credit inquiries.
  • RxERP FinancialcoreGTM or Marketing Partner · 9 October 2025Joint financing initiative with Wellgistics Health enabling working capital access for pharmacies and supply chain partners. RxERP Financial brand powers the capital access program integrated into the platform.

Scale indicators5 records

Recent moves6 records

Expansion highlights6 records

RxERP competitors and assessment

Company assessment

Direct peers

  • TraceLink: TraceLink is a leading pharmaceutical serialization and supply chain traceability network, directly comparable to RxERP's DSCSA-focused serialization capabilities, but with a broader network-orchestration focus rather than a unified ERP core.
  • Systech (Markem-Imaje): Systech offers unit-level serialization, traceability, and authentication solutions for pharmaceutical supply chains, overlapping with RxERP's serialization-native ERP positioning for manufacturers and packagers.
  • rfXcel (now Körber Pharma Track & Trace): rfXcel provides pharmaceutical serialization, traceability, and compliance software serving manufacturers, wholesalers, and 3PLs. It is the closest direct competitor to RxERP's DSCSA-compliance value proposition.
  • Antares Vision Group: Antares Vision provides serialization, track-and-trace, and quality control solutions for the pharmaceutical industry, competing in the same DSCSA compliance and unit-level traceability space as RxERP.

Broad incumbents

  • SAP S/4HANA: SAP is the dominant broad-incumbent ERP for large pharmaceutical manufacturers and distributors, with serialization and compliance modules that compete with RxERP's vertically-specialized pharma offering.
  • Blue Yonder: Blue Yonder provides supply chain planning and execution software used by pharmaceutical distributors and 3PLs, overlapping with RxERP's inventory, ordering, and 3PL solutions.
  • Körber Pharma Software: Körber offers a portfolio of pharma manufacturing, serialization, and supply chain software solutions, making it a broad incumbent peer with overlapping DSCSA and warehouse execution capabilities.
  • Oracle NetSuite / Oracle ERP: Oracle offers broad enterprise ERP platforms used by pharma manufacturers and distributors, including serialization extensions. As a broad incumbent, it competes against RxERP for enterprise pharma wallet share.
  • Microsoft Dynamics 365: Microsoft Dynamics 365 is a broad ERP/CRM platform with growing traction in regulated industries including pharma distribution, positioning it as a broad incumbent alternative to RxERP's serialized ERP.

Emerging players

  • LSPediA (Veeva): LSPediA, now part of Veeva, provides DSCSA compliance and serialization software for the pharmaceutical supply chain, positioning it as a closely adjacent emerging player to RxERP's serialization focus.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights6 records

Customer concentration

RxERP social profiles

Digital presence

RxERP compliance and trust

Trust signal

Compliance1 record

RxERP financial estimates

Financial estimate

Revenue estimate

Valuation estimate

RxERP leadership team

Management profile

Number of profiles

Profiles4 records

RxERP funding detail

Funding detail

Funding overview

Funding rounds1 record

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

RxERP M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about RxERP

What does RxERP do?

RxERP provides a fully serialized, AI-native ERP platform built specifically for the pharmaceutical supply chain, unifying DSCSA serialization, compliance, inventory, financial automation, CRM, eCommerce, and analytics in a single system. The platform replaces 4-6 disconnected tools with one system of record serving manufacturers, wholesale distributors, 3PL providers, micro-distributors, and government programs. The 2026 Hub upgrade added unit-level audit logging, automated transaction guardrails, and p-Chip microtransponder integration.

Is RxERP a public or private company?

RxERP is a private company. It is classified as venture growth investor backed and is currently operating.

When was RxERP founded?

RxERP was founded in 2020. It employs 11 to 50 people.

Where is RxERP based?

RxERP is headquartered in Saint George, United States, in the North America region.

How does RxERP make money?

Three revenue lines are on record. SaaS Subscription is the primary driver. The others are financing Program Revenue and professional Services.

Who are RxERP's main competitors?

Direct peers on record are TraceLink, Systech (Markem-Imaje), rfXcel (now Körber Pharma Track & Trace) and Antares Vision Group. Broad incumbents are SAP S/4HANA, Blue Yonder, Körber Pharma Software, Oracle NetSuite / Oracle ERP and Microsoft Dynamics 365. LSPediA (Veeva) is listed as an emerging player.

Does RxERP have an API?

No public API is recorded for RxERP.

What industry is RxERP in?

RxERP's product category is Pharmaceutical Serialized ERP Software. Its primary akta.pro industry code is HDAEAEAH, Healthcare Provider ERP (Hospital Operations, Supply Chain, Finance). Its NAICS code is 5132 and its SIC code is 7373.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
Business Wire BlogRxERP Wins Gold in Two Categories at the 2026 Merit Awards for HealthcareRxERP won Gold in the Pharma and Innovations categories at the 2026 Merit Awards for Healthcare. The pharmaceutical ERP platform builds DSCSA compliance directly into its core system, and its April 2026 Hub upgrade added unit-level audit logging and EDI integration.FinancialContent Business PageRxERP Wins Gold in Two Categories at the 2026 Merit Awards for HealthcareRxERP won Gold in the Pharma and Innovations categories at the 2026 Merit Awards for Healthcare. The pharmaceutical ERP platform integrates DSCSA compliance, serialization, and EDI into its core system. The awards were announced on November 5, 2026.FinancialContent Business PageRxERP Names Mary Vrana EDI Program Manager to Speed Pharmaceutical Trading-Partner ConnectionsRxERP appointed Mary Vrana as EDI Program Manager to accelerate pharmaceutical trading-partner connections. She brings over seven years of EDI experience across the supply chain and will lead efforts to reduce mapping and testing time. The company aims to simplify EDI workflows using AI.FinancialContent Business PageCedra Healthcare Selects RxERP to Support Compliant Expansion into Pharmaceutical DistributionCedra Healthcare deployed RxERP, a serialized ERP platform, to support its pharmaceutical distribution expansion. The system replaces manual serialization workflows with DSCSA-compliant processes, enabling growth in its Texas and New York operations. The deployment aims to prevent compliance gaps as distribution volume increases.Business Wire BlogCedra Healthcare Selects RxERP to Support Compliant Expansion into Pharmaceutical DistributionCedra Healthcare deployed RxERP, a serialized ERP platform, to support its pharmaceutical distribution expansion. The system replaces manual serialization workflows with DSCSA-compliant processes, enabling growth in its Texas and New York operations. The deployment aims to prevent compliance gaps as distribution volume increases.Business Wire BlogRxERP and p-Chip Corporation to Present Hardware-Backed Item Identity Solution at GS1 Connect 2026RxERP and p-Chip Corporation will jointly present their hardware-backed item identity solution at GS1 Connect 2026 in Las Vegas on June 10, 2026. The session demonstrates binding unit-level digital anchors to GS1 identifiers and EPCIS events to strengthen pharmaceutical traceability. The companies invite stakeholders to discuss pilot lanes and commercial deployment.Business Wire BlogIndependent Pharmaceutical Partners with RxERP to Complete Full ERP Transition Through New Hub PlatformRxERP, a pharmaceutical supply chain infrastructure provider, announced a multimillion-dollar partnership with Independent Pharmaceutical LLC, a wholesale pharmaceutical distributor, to transition the latter's enterprise resource planning operations to RxERP's newly launched Hub platform. The platform is purpose-built for pharmaceutical distribution, inventory management, serialization, DSCSA compliance, and regulatory reporting. The collaboration is designed to strengthen Independent Pharmaceutical's compliance infrastructure as the company expands in both prescription and over-the-counter distribution.National TodayRxERP Releases Major Upgrade to Serialized ERP SolutionRxERP, a provider of ERP software for pharmaceutical and medical device industries, has released a major upgrade called 'The Hub' to its serialized ERP solution. The upgrade includes improved lot and serial number tracking, enhanced reporting and analytics, and tighter integration with other enterprise systems, aimed at helping companies manage serialized inventory and ensure regulatory compliance. The company announced the release on April 8, 2026.Business Wire BlogRxERP Releases The Hub, a Major Upgrade to its Industry-Leading Serialized ERP Solution for the Pharmaceutical Supply ChainRxERP announced the release of "The Hub," a major upgrade to its serialized ERP and pharmaceutical inventory management platform, introducing unit-level audit logging, infrastructure-grade capabilities, and automated transaction guardrails for the pharmaceutical supply chain. The upgrade transforms RxERP into a foundation layer enabling compliant operation by default, faster risk identification, and reduced operational drag across serialized transactions. Steve Madsen, CEO of RxERP, stated that the release creates verified transaction rails that become sources of truth for the pharma ecosystem.BitgetRxERP's Hub: The Absence of a Central "Source of Truth" in Pharma Supply Chains May Lead to a Data MonopolyRxERP has launched a major platform upgrade called "The Hub," positioning itself as the pharmaceutical sector's foundational data infrastructure with a single, serialized system of record and unit-level audit trails. The company aims to evolve from a compliance solution to a utility-like platform where value grows with each connected transaction, capitalizing on a market projected to nearly double by 2030 with a 12% CAGR driven by DSCSA and FMD regulations. RxERP faces significant challenges including industry fragmentation, capital flowing toward drug development rather than infrastructure, and competition from established ERP vendors and niche supply chain platforms, with its success dependent on becoming the default standard for contract packaging organizations.